Navigation Links
China Biologic Reports Financial Results for the Second Quarter and First Half of 2013
Date:8/6/2013

ional non-GAAP information is not meant to be considered in isolation or as a substitute for GAAP financials. The non-GAAP financial information that the Company provides also may differ from the non-GAAP information provided by other companies.

Safe Harbor StatementThis news release may contain certain "forward-looking statements" relating to the business of China Biologic Products, Inc. and its subsidiaries. All statements, other than statements of historical fact included herein, are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions, and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect.

Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including its potential inability to achieve the expected operating and financial performance in 2013, potential inability to find alternative sources of plasma, potential inability to increase production at permitted sites, potential inability to mitigate the financial consequences of a temporarily reduced raw plasma supply through cost cutting or other efficiencies, and potential additional regulatory restrictions on its operations and those additional risks and uncertainties discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BD and the College of American Pathologists Announce Strategic Alliance to Support Laboratory Quality and Performance in India and China
2. China Biologic Products to Report Second Quarter 2013 Financial Results
3. MEDTEC China 2013: Floor space sold out!
4. China Heart Valve Market and Heart Lung Machine Industry Global Analysis in New Research Reports
5. Kinex Pharmaceuticals Will Take the Lead in the Orascovery Program Development in China
6. Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
7. China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration
8. Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
9. Research Report on Chinas High-End Medical Treatment Industry, 2013-2017
10. China Biologic Waived Application of Preferred Shares Rights Agreement
11. China Botanic Pharmaceutical Inc. Announces Withdrawal Of Request For Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
(Date:5/6/2015)... May 05, 2015 Research and Markets ... of the "Chromatography (Instruments and Reagents) Global ... their offering. Chromatography is an analytical ... component of a complex mixture by differential movement ... the scientists have considered chromatography as an esoteric ...
(Date:5/6/2015)... 2015   CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... treatment at the EUROHEADPAIN - Midterm Meeting at the ... , from May 14-17, 2015. On ... a major European research project focused on migraines, ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... NEW YORK, April 21, 2011 Amgen (NASDAQ: ... and provided financial guidance for 2015 during a meeting with ... CEO opened the meeting by outlining key elements of the ... advance treatment of serious illness; Make significant and ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 2Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 3Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 4Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 5Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 7Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 8
(Date:5/6/2015)... (PRWEB) May 07, 2015 New ... NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May 27, 2015 — ... , Most drugs contain 70-90% excipients, which ... agents or other purposes that facilitate the manufacturing ... the pharma industry, combined with a regulatory focus ...
(Date:5/6/2015)... RPS Revolution - a game for the ... true Rock Paper Scissors game - is now taking ... storytelling and easy to learn rules from Rock Paper Scissors, ... favorite. RPS Revolution takes the best parts of ... are grouped in set of three called Trios. Trios like ...
(Date:5/6/2015)... May 06, 2015 As Hilo ... HIMSS EMR Adoption Model, the hospital looked for ... engagement and automate processes. The leadership team realized ... to electronic workflows, patient registration still required patients ... consents. With HIMSS Stage 7 attestation fast approaching, ...
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... The Beryl Institute announces the publication ... Experience Journal (PXJ), an international, open access, peer-reviewed journal ... improving patient experience. The second volume of PXJ supports ... helps align the voices engaged and provides the space ... association with The Beryl Institute, Volume 2, Issue 1 ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2
... therapy of Prostacyclin, Sildenafil, and Bosentan helped a ... enough to receive a liver transplant. It was ... health. These findings are published in the March ... Wiley & Sons. The article is also available ...
... between two closely related strains of the influenza A ... flu epidemics, according to biologists. The findings could help ... lead to seasonal epidemics., Until now, it was believed that ... with influenza viruses that infect birds causes severe ...
... WASHINGTON, March 4 Enrollment in,Consumer-Directed Health Plans ... health care information tools to employees in order,to ... to a study,commissioned by the American Association of ... Inc., (Logo: http://www.newscom.com/cgi-bin/prnh/20060126/CLTH062LOGO ), ...
... BlueCross BlueShield of South,Carolina announced today that the second ... lunchtime hours on Wednesday, April 30, 2008., Blue ... well as,other employers, will encourage their employees to wear ... a 30-minute lunchtime walk., The motivation behind National ...
... launch of the latest fleet golf car and the ... Inc., a leader in,manufacturing execution systems (MES) for the ... online event,titled "Launching the E-Z-GO Fleet Golf Car: Integrating ... will,take place on Thursday, March 6, 2008 at 2:00 ...
... heighten accuracy with Microsoft Dynamics ... ... that AliMed, a producer and catalog-based distributor of medical,products, has chosen ... its business and expanding its interaction with,customers. The technology will enable ...
Cached Medicine News:Health News:A combination therapy of 3 vasodilators may treat portopulmonary hypertension 2Health News:Study uncovers cause of flu epidemics 2Health News:Study uncovers cause of flu epidemics 3Health News:Consumer-Directed Health Plans Continue to Grow as Popular Vehicle to Bring Choice, Flexibility and Access to Consumers 2Health News:Consumer-Directed Health Plans Continue to Grow as Popular Vehicle to Bring Choice, Flexibility and Access to Consumers 3Health News:S.C. BlueCross Announces Second Annual National Walk @ Lunch Day 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 2Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 4Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 5
... The Equalizer With 384 Well Plate Capability ... revolutionary features of the original Equalizerexpandable and equal ... components, and in-lab calibration capabilities. In addition, this ... down to 4.5mm for loading and accessing many ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
... transfer samples from 96-well plates ... Accurately deliver 0.5-5 μl. Complete ... six minutes or less. Compatible ... and other gels with microwell ...
... Equally Spaced, Expandable, Multichannel Pipettor ... pipettors and instantly boosts productivity with an ... the simple adjustment of a slide rod. ... transfer of liquids between vessels with different ...
Medicine Products: